One major part of funding R&D with grant or non-dilutive funding is understanding the timeline for this sort of funding. While academic researchers can be accustomed to the slow pace of the process, it can feel glacial for startups accustomed to moving at the speed of pharma. But there’s no denying this: the benefit of non-dilutive funding can definitely outweigh the advance planning required to make it happen. Continue reading “Don’t Let COVID-19 Derail Your R&D Funding”
Updated 12 December 2017.
Just a quick reminder to everyone to set some time aside over the holidays to review changes to NIH policy (e.g., clinical trials) before drafting a funding strategy for 2018. The new year is a great time to recommit to your funding pursuit and do some deep work on crafting a funding strategy and drafting some proposals, but that energy will be misspent if you haven’t spent some time catching up with NIH policies effective in the new year. So here are 4 great sources for news everyone applying for funding should know. Continue reading “4 Quick Ways to Catch up on Critical Changes to Federal Grant Applications and Processes”